Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
Pegylated Liposomal Doxorubicin as well as Carboplatin have been showed efficacy in
monotherapy as in combination therapy of gynaecologic tumours. As there is no common standard
in the therapy of recurrent ovarian carcinoma, tumours of the uterus nor for non-epithelial
ovarian tumours at time of designing of this study, this trial shall evaluate the new and
well tolerated combination therapy consisting of Pegylated Liposomal Doxorubicin and
Carboplatin.